Literature DB >> 3706801

Hemodynamic effects of isoflurane in the newborn piglet: comparison with halothane.

R A Schieber, A Namnoum, A Sugden, G K Shiu, R A Orr, D R Cook.   

Abstract

To better understand the mechanism of hypotension and bradycardia that may occur in newborn infants during isoflurane anesthesia, we studied the hemodynamic changes in the major determinants of cardiac output in 15 newborn piglets given 0.5, 1.0, and 1.3 minimal alveolar concentrations (MAC) of isoflurane and in nine sham-instrumented, age-matched control animals. Cardiac output did not differ from the baseline reading or the control group at any isoflurane dose. Mean aortic pressure (MAP) decreased 23-45% in a dose-related manner. Total peripheral resistance index (TPRI) decreased 29% at 0.5 MAC, but did not decline further at higher concentrations. Because the decrease in MAP was offset by a similar reduction in TPRI, cardiac output did not change. Heart rate decreased significantly at 1.3 MAC (-19%). Contractility was depressed at all concentrations: left ventricular dP/dT decreased progressively at 0.5 and 1.0 MAC, and echocardiographic shortening fraction decreased significantly at 1.0 MAC. Left ventricular end-diastolic pressure was not affected. Eight of twelve animals who had bradycardia while breathing isoflurane were atrially paced at their baseline heart rate. Because pacing did not restore MAP, TPRI, and LV dP/dT/DP40 (a contractile index independent of preload and afterload) to control values, bradycardia was not primarily responsible for depression of these variables. At equipotent concentrations, isoflurane reduced MAP and TPRI more than, and cardiac output less than, halothane did in previous studies in this laboratory. Heart rate and dP/dT were decreased to a similar extent by both agents. Blood, heart, and brainstem isoflurane LD:MAC ratios were 2.04, 2.00, and 2.84, respectively, indicating a relatively low margin of safety for isoflurane in young piglets.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3706801

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  5 in total

1.  Isoflurane and halothane impair both systolic and diastolic function in the newborn pig.

Authors:  M R Graham; D B Thiessen; W A Mutch
Journal:  Can J Anaesth       Date:  1996-05       Impact factor: 5.063

2.  Haemodynamic effects of atropine during halothane or isoflurane anaesthesia in infants and small children.

Authors:  D J Murray; R B Forbes; J B Dillman; L T Mahoney; D L Dull
Journal:  Can J Anaesth       Date:  1989-05       Impact factor: 5.063

3.  Mechanism of decreased forward stroke volume in children and swine with ventricular septal defect and failure to thrive.

Authors:  W J Corin; M M Swindle; J F Spann; K Nakano; M Frankis; R W Biederman; A Smith; A Taylor; B A Carabello
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

4.  Paradox of age: older patients receive higher age-adjusted minimum alveolar concentration fractions of volatile anaesthetics yet display higher bispectral index values.

Authors:  Katherine Ni; Mary Cooter; Dhanesh K Gupta; Jake Thomas; Thomas J Hopkins; Timothy E Miller; Michael L James; Miklos D Kertai; Miles Berger
Journal:  Br J Anaesth       Date:  2019-07-03       Impact factor: 9.166

5.  Best Practices for Postoperative Brain Health: Recommendations From the Fifth International Perioperative Neurotoxicity Working Group.

Authors:  Miles Berger; Katie J Schenning; Charles H Brown; Stacie G Deiner; Robert A Whittington; Roderic G Eckenhoff; Martin S Angst; Sinziana Avramescu; Alex Bekker; Marek Brzezinski; Greg Crosby; Deborah J Culley; Maryellen Eckenhoff; Lars I Eriksson; Lis Evered; Jim Ibinson; Richard P Kline; Andy Kofke; Daqing Ma; Joseph P Mathew; Mervyn Maze; Beverley A Orser; Catherine C Price; David A Scott; Brendan Silbert; Diansan Su; Niccolo Terrando; Dian-Shi Wang; Huafeng Wei; Zhoncong Xie; Zhiyi Zuo
Journal:  Anesth Analg       Date:  2018-12       Impact factor: 6.627

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.